CBOE · ADME
Aptus Drawdown Managed Equity ETF
$55.53-$0.83 (-1.47%)
Aptus Drawdown Managed Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.29% below the high.
Loading market information…
AMEX · GDNA · USD
Stock price, dividends
Quote as of Nov 6, 2020, 08:41 PM UTC. Cached market data; not a live quote.
Price history is currently unavailable.
Goldman Sachs Human Evolution ETF’s quoted price sits in the upper half of its reported 52-week range, 0.48% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Goldman Sachs Human Evolution ETF’s forward annual dividend is $2.21 per share, paid monthly. The forward yield is 3.23% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
This fund's primary objective is to achieve investment returns that closely track the performance of the Goldman Sachs Human Evolution Index, prior to accounting for fees and expenses. To accomplish this, the fund allocates at least 80% of its total assets to the equities that comprise its underlying index. The index itself is constructed to provide exposure to common stocks of companies in specific developed markets. These companies are identified for their potential to capitalize on breakthroughs in scientific knowledge, pharmaceutical development, and technological innovations related to human medical care, addressing conditions throughout an individual's entire life journey, from birth to end-of-life.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 07:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$55.53-$0.83 (-1.47%)
Aptus Drawdown Managed Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.29% below the high.
$37.91-$0.17 (-0.44%)
AllianzIM U.S. Equity Buffer20 Apr ETF’s quoted price sits in the upper half of its reported 52-week range, 0.47% below the high.
$77.71+$0.11 (+0.14%)
Invesco S&P 500 Value with Momentum ETF’s quoted price sits in the upper half of its reported 52-week range, 1.6% below the high.
$54.27-$0.28 (-0.52%)
Invesco Bloomberg MVP Multi-factor ETF’s quoted price sits in the upper half of its reported 52-week range, 1.65% below the high.
$31.23-$0.34 (-1.06%)
Abacus FCF Real Assets Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 8.4% below the high.
$0.25$0.00 (0.0%)
VanEck Green Infrastructure ETF’s quoted price sits in the lower half of its reported 52-week range, 98.99% below the high.
$7.45+$0.03 (+0.4%)
VelocityShares 1x Daily Inverse VSTOXX Futures ETN’s quoted price sits in the lower half of its reported 52-week range, 84.12% below the high.
$25.52+$0.28 (+1.11%)
Alpha Dog ETF’s quoted price sits in the upper half of its reported 52-week range, 1.55% below the high.
